Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Fatty liver disease
Metabolic dysfunction and alcohol associated liver disease
A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is distinguished from MASLD by increased alcohol consumption and from ALD by the evidence of one or more of the MASLD cardiometabolic risk factors.
This condition has no sub-types.